Skip to content

Clinical trials

Carcinoma, Ovarian Epithelial trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Country / region: South Korea Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20102
20111
20122
20141
20161
20171
20181
20192
20203
20213
20225
20233
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed9
Active, not recruiting7
Terminated4
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center4
National Cancer Center, Korea4
AstraZeneca3
AbbVie1
Amgen1
Bristol-Myers Squibb1
CanariaBio Inc.1
Chong Kun Dang Pharmaceutical1
Daiichi Sankyo1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial33
Fallopian Tube Neoplasms14
Ovarian Neoplasms13
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Triple Negative Breast Neoplasms4
Uterine Cervical Neoplasms4
Breast Neoplasms3
Endometrial Neoplasms3

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.